Collaborative COVID-19 lockdown effort delivers major boost for vaccine innovation in Bristol7 September 2021Faster vaccine development could be a step closer thanks to £4 million investment to Imophoron Ltd, a Bristol University biotech start-up developing a novel, next generation rapid-response vaccine platform called ADDomer™. Imophoron will use the investment to bring ADDomer vaccines to clinical stage, initially targeting three viruses, RSV (respiratory syncytial virus), COVID-19, and mosquito-borne Chikungunya.
From racehorse to therapy horse: pioneering study into welfare of horses who help people6 September 2021A new study will examine the selection, training and welfare of thoroughbred horses as they transition from racetrack to therapy horse. The pioneering project, led by academics at the University of Bristol’s Veterinary School in collaboration with Racing to Relate, will develop a recognised global welfare standard for former racehorses who are moving into Equine Assisted Therapy (EAT).
GW4 takes a world leading One Health approach to tackling the antimicrobial resistance pandemic17 June 2021The GW4 Alliance (Bath, Bristol, Cardiff and Exeter universities – GW4) formally launched their new ‘One Health’ antimicrobial resistance research consortium this week [Wednesday 16 June]. The World Health Organisation cites antimicrobial resistance (AMR) as one of the most significant risks facing the world. AMR threatens global health and development as it impacts on human, animal and plant health and also our environment, water safety and food security.
Dog’s body size and shape could indicate a greater bone tumour risk10 March 2021Osteosarcoma is a painful and aggressive bone tumour in dogs that is known to be more common in certain breeds than others. New research has now confirmed that larger breeds, such as Rottweiler, Great Dane and Rhodesian Ridgeback, have a greater risk of osteosarcoma than smaller breeds, as well as showing that breeds with shorter skulls and legs have lower osteosarcoma risk. The findings could inform future breed health reforms as well as studies into the way tumours develop from normal bone.
RCVS Knowledge launches next generation of popular evidence-based veterinary medicine course6 March 2021RCVS Knowledge has updated and expanded its highly regarded EBVM Learning course to provide a free, practical grounding in applying evidence-based veterinary medicine (EBVM), available on the charity’s new elearning platform. The new version of EBVM Learning is the product of an international collaboration with 18 leading veterinary educators and practitioners including Emeritus Professor Sarah Baillie from the Bristol Vet School. It offers veterinary surgeons, nurses, students and educators six hours of free CPD, which cover the five stages of EBVM and an overview of its evolution.
Science finds simple way to make lamb leaner14 January 2021Scientists based at Rothamsted and the University of Bristol Veterinary School have found a clear link between the weight of lambs early in their life and meat quality – which is good news for consumers, farmers, and the environment.